Submission date
15/02/2002
Registration date
15/02/2002
Last edited
06/09/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Retrospectively registered
Protocol added
? SAP not yet added
Results added
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr Diederik WJ Dippel

ORCID ID

Contact details

Dept of Neurology
University Hospital Rotterdam
PO Box 2040
Rotterdam
3000 CR
Netherlands
+31 (0)10 4639222
dippel@neuro.fgg.eur.nl

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Acronym

PISA

Study hypothesis

To study the effect of high-dose ibuprofen and to confirm the previously observed reducing effect of high-dose paracetamol on body temperature, and to study their safety in normothermic and subfebrile patients with acute ischaemic stroke.

Ethics approval(s)

The medical ethics committees of the three hospitals have approved this protocol.

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Hospital

Study type

Treatment

Patient information sheet

Condition

Stroke

Intervention

1. Paracetamol 6 g daily, for 5 days
2. Ibuprofen 2.4 g daily, for 5 days
3. Placebo for 5 days

Intervention type

Drug

Pharmaceutical study type(s)

Phase

Phase II

Drug/device/biological/vaccine name(s)

Paracetamol (acetaminophen), ibuprofen

Primary outcome measure

Body temperature at 24 hours from start of treatment.

Secondary outcome measures

1. Change in baseline temperature at 1 and 5 days from start of treatment
2. Time with elevated body temperature (greater than 37.0°C) (area under the curve) during the first 24 hours and the first five days

Tertiary outcomes:
Functional outcome at one month, as determined by the scores on the modified Rankin Scale (mRS) and Barthel Index (BI).

Overall study start date

01/12/2000

Overall study end date

31/12/2001

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

1. An acute ischaemic anterior circulation stroke
2. A body temperature greater than 36.0°C or less than 39.0°C
3. A CT scan that is compatible with acute ischaemic stroke
4. A focal deficit without rapid improvement
5. A possibility to start treatment within 24 hours after stroke onset

Participant type(s)

Patient

Age group

Not Specified

Sex

Not Specified

Target number of participants

75

Participant exclusion criteria

1. Severe aphasia, defined as an aphasia score of 2 or 3 on the National Institutes of Health Stroke Scale (NIHSS)
2. Treatment with an non-Steroidal Anti-Inflammatory Drug (NSAID) deemed necessary
3. Hypersensitivity to ibuprofen or paracetamol
4. (Chronic) liver failure or cirrhosis
5. (Chronic) renal failure
6. History of alcohol abuse
7. Active gastric ulcer disease or a history of peptic ulceration or gastro-intestinal haemorrhage in the preceding year
8. Colitis ulcerosa
9. Pregnancy
10. Use of corticosteroids
11. A severe concomitant medical condition that could affect the assessment of the effect of the study medication on temperature
12. Residual neurological impairment resulting from a previous stroke that may hamper the assessment of functional outcome
13. Death appearing imminent
14. No informed consent given

Recruitment start date

01/12/2000

Recruitment end date

31/12/2001

Locations

Countries of recruitment

Netherlands

Study participating centre

Dept of Neurology
Rotterdam
3000 CR
Netherlands

Sponsor information

Organisation

Erasmus Medical Center (The Netherlands)

Sponsor details

P.O. Box 1738
Rotterdam
3000 DR
Netherlands

Sponsor type

Hospital/treatment centre

Website

http://www.erasmusmc.nl/content/englishindex.htm

ROR

https://ror.org/018906e22

Funders

Funder type

Research organisation

Funder name

Rotterdam Neurovascular Research Foundation (Stichting Neurovasculair Onderzoek Rotterdam) (The Netherlands)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article Protocol 27/03/2002 Yes No
Results article Results 06/02/2003 Yes No

Additional files

Editorial Notes